The Belgium Financial Services and Markets Authority announced that trading in Celyad Oncology financial instruments (ISIN BE0974260896) on Euronext Brussels will resume on 12 February 2026 at 09:00 CET.
Belgium Financial Services and Markets Authority 2026-02-12
Belgium Financial Services and Markets Authority announces reopening of Celyad Oncology trading on Euronext Brussels at 09:00 CET
The Belgium Financial Services and Markets Authority stated that trading in Celyad Oncology financial instruments on Euronext Brussels will resume on 12 February 2026 at 09:00 CET.